
pmid: 27539690
The addition of dual antiplatelet (DAPT) therapy to oral anticoagulant triples the risk of major bleeding complications [(1–4)][1]. Patients who are exposed to triple therapy should be considered at high risk for bleeding given the fact that, in addition to the risk of triple therapy itself, most
Ticlopidine, Atrial Fibrillation, Anticoagulants, Drug Therapy, Combination, Platelet Aggregation Inhibitors
Ticlopidine, Atrial Fibrillation, Anticoagulants, Drug Therapy, Combination, Platelet Aggregation Inhibitors
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
